Aarti Pharmalabs Ltd.

The March 2024 quarter revenue stood at Rs. 4148.20 millions, up 10.83% as compared to Rs. 3742.70 millions during the corresponding quarter last year.Handsome Net Profit growth of 57.59% reported above the corresponding previous quarter figure of Rs. 630.20 millions to Rs. 399.90 millions.OP of the company witnessed a marginal growth to 1130.20 millions from 768.00 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202403	202303	% Var	202403	202303	% Var	202403	202303	% Var
Sales	4148.20	3742.70	10.83	15021.30	15112.50	-0.60	15021.30	15112.50	-0.60
Other Income	56.80	0.00	0.00	110.10	12.80	760.16	110.10	12.80	760.16
PBIDT	1130.20	768.00	47.16	3571.60	3096.20	15.35	3571.60	3096.20	15.35
Interest	44.20	58.00	-23.79	166.30	204.90	-18.84	166.30	204.90	-18.84
PBDT	1086.00	710.00	52.96	3405.30	2891.30	17.78	3405.30	2891.30	17.78
Depreciation	173.20	142.50	21.54	660.10	557.70	18.36	660.10	557.70	18.36
PBT	912.80	567.50	60.85	2745.20	2333.60	17.64	2745.20	2333.60	17.64
TAX	282.60	167.60	68.62	738.70	616.30	19.86	738.70	616.30	19.86
Deferred Tax	165.60	27.60	500.00	278.10	95.00	192.74	278.10	95.00	192.74
PAT	630.20	399.90	57.59	2006.50	1717.30	16.84	2006.50	1717.30	16.84
Equity	453.10	453.10	0.00	453.10	453.10	0.00	453.10	453.10	0.00
PBIDTM(%)	27.25	20.52	32.78	23.78	20.49	16.05	23.78	20.49	16.05